MedPath

Comparison of the effect of Citicoline on the cognitive-behavioral performance of autism spectrum patients with standard treatments

Phase 3
Recruiting
Conditions
Autism spectrum disorder.
Autistic disorder
F84.0
Registration Number
IRCT20231030059898N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Primary diagnosis of autism using MCHAT test in children under 3 years old and CARS test in children over 3 years old

Exclusion Criteria

Intractable seizures, high blood pressure, underlying diseases such as diabetes and asthma, and lack of parental consent to enter the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MCHAT test score for under 3 years old and CARS test for over 3 years old. Timepoint: The beginning of the study and 2 months later. Method of measurement: MCHAT test for under 3 years old and CARS test for over 3 years old.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath